Literature DB >> 27283012

Challenges in pancreas transplantation.

E J Sharples1, S M Mittal2, P J Friend3.   

Abstract

Whole-organ pancreas transplantation, either alone or combined with a kidney transplant, is the only definitive treatment for many patients with type 1 diabetes that restores normal glucose homoeostasis and insulin independence. Pancreas transplantation delays, or potentially prevents, secondary diabetes complications and is associated with improvement in patient survival when compared with either patients remaining on the waiting list or those receiving kidney transplant alone. Pancreas transplantation is safe and effective, with 1-year patient survival >97 % and graft survival rates of 85 % at 1 year and 76 % at 5 years in recent UK data. This review focuses on some current areas of interest in pancreas transplantation.

Entities:  

Keywords:  Diabetes; Incretin; Pancreas transplant

Mesh:

Substances:

Year:  2016        PMID: 27283012     DOI: 10.1007/s00592-016-0865-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

1.  Xenotransplantation of Genetically Modified Neonatal Pig Islets Cures Diabetes in Baboons.

Authors:  Wayne J Hawthorne; Evelyn J Salvaris; Yi Vee Chew; Heather Burns; Joanne Hawkes; Helen Barlow; Min Hu; Andrew M Lew; Mark B Nottle; Philip J O'Connell; Peter J Cowan
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  Pancreatic Islet Changes in Human Whole Organ Pancreas Explants: What Can Be Learned From Explanted Samples?

Authors:  Richard Dumbill; Hannah Laurenson-Schafer; Edward J Sharples; James Barnes; Shruti Mittal; Peter J Friend; Anne Clark
Journal:  Transplant Direct       Date:  2020-10-19

Review 3.  [Pancreas transplantation-clinic, technique, and histological assessment].

Authors:  Maike Büttner-Herold; Kerstin Amann; Frederick Pfister; Andrea Tannapfel; Marina Maslova; Andreas Wunsch; Nina Pillokeit; Richard Viebahn; Peter Schenker
Journal:  Pathologe       Date:  2021-08-20       Impact factor: 1.011

Review 4.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

5.  Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice.

Authors:  Wenjuan Liu; Dong Ok Son; Harry K Lau; Yinghui Zhou; Gerald J Prud'homme; Tianru Jin; Qinghua Wang
Journal:  Front Pharmacol       Date:  2017-06-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.